Dutasteride Therapeutic Cheat Sheet
Androgenic alopecia (AGA) is one of the most common forms of hair loss and represents a frequently faced disabling concern in dermatology visits. Targeting the 5α-dihydrotestosterone (DHT) pathway has been shown to be an efficacious mechanism of action, with finasteride being the only systemic FDA-approved drug to treat male AGA. Recently, its sister drug, dutasteride, has been increasingly utili …
Androgenic alopecia (AGA) is one of the most common forms of hair loss and represents a frequently faced disabling concern in dermatology visits. Targeting the 5α-dihydrotestosterone (DHT) pathway has been shown to be an efficacious mechanism of action, with finasteride being the only systemic FDA-approved drug to treat male AGA. Recently, its sister drug, dutasteride, has been increasingly utili … 
Allure recently posted an article, "Is My Acne the Reason I Can't Sleep?" What does research say about a link between acne and sleep, and how should dermatologists counsel their acne patients about lifestyle factors?
For expert advice, I reached out to Miami dermatologist Heather Woolery-Lloyd, MD, who is board certified in both dermatology and lifestyle medicine. Dr. Woolery-Lloyd spoke ab … 
We have probably all seen a patient with rosacea. After all, it is quite common in middle-aged, fair-skinned women. Here, however, we will explore a talk given by Dr. Hilary Baldwin (Medical director of the Acne Treatment & Research Center in Morristown, NJ and Brooklyn, NY, and Clinical Associate Professor of Dermatology at Rutgers Robert Wood Johnson Medical Center) at the 2022 Skin of Color … 
INSIDER recently posted an article on oral minoxidil for hair loss as a result of media coverage in The New York Times. Which hair loss patients make good candidates for oral minoxidil? How should a dermatologist determine the best dosage for their patients?
For expert advice, I reached out to Shilpi Khetarpal, MD, FAAD, director of cosmetic dermatology and lasers at the Cleveland Clinic.
… 
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed board-certified dermatologist and dermatologic surgeon Dr. Brad Glick on his approach to patients with cutaneous signs of systemic disease.
Watch as he shares many examples of common and less common systemic diseases with dermatolog … 